170 related articles for article (PubMed ID: 17047598)
21. Ivabradine: beyond heart rate control.
Riccioni G; Vitulano N; D'Orazio N
Adv Ther; 2009 Jan; 26(1):12-24. PubMed ID: 19165437
[TBL] [Abstract][Full Text] [Related]
22. The discovery of the selective I(f) current inhibitor ivabradine. A new therapeutic approach to ischemic heart disease.
Vilaine JP
Pharmacol Res; 2006 May; 53(5):424-34. PubMed ID: 16638639
[TBL] [Abstract][Full Text] [Related]
23. [Antianginal efficacy and tolerability of ivabradine in the therapy of patients with stable angina: results of the CONTROL study].
Glezer MG; Saĭgitov RT
Kardiologiia; 2010; 50(11):65-75. PubMed ID: 21526568
[TBL] [Abstract][Full Text] [Related]
24. [Possibilities of reducing heart rate by I(f)-channel inhibitors].
Hennersdorf MG
Med Klin (Munich); 2006 Mar; 101 Suppl 1():150-2. PubMed ID: 16802542
[TBL] [Abstract][Full Text] [Related]
25. [Ivabradine -- a novel approach for heart rate lowering].
Er F; Hoppe UC
Dtsch Med Wochenschr; 2005 Jun; 130(24):1501-2. PubMed ID: 15942839
[No Abstract] [Full Text] [Related]
26. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.
Swedberg K; Komajda M; Böhm M; Borer J; Robertson M; Tavazzi L; Ford I;
J Am Coll Cardiol; 2012 May; 59(22):1938-45. PubMed ID: 22617188
[TBL] [Abstract][Full Text] [Related]
27. [Why it is necessary to reduce heart rate in the treatment of stable angina?].
Makolkin VI; Ziabrev FN
Kardiologiia; 2006; 46(9):88-91. PubMed ID: 17047624
[TBL] [Abstract][Full Text] [Related]
28. Long-term safety and efficacy of ivabradine in patients with chronic stable angina.
López-Bescós L; Filipova S; Martos R
Cardiology; 2007; 108(4):387-96. PubMed ID: 17890862
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of I(f) inhibition with ivabradine in different subpopulations with stable angina pectoris.
Tendera M; Borer JS; Tardif JC
Cardiology; 2009; 114(2):116-25. PubMed ID: 19468225
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of ivabradine in combination with Beta-blocker versus uptitration of Beta-blocker in patients with stable angina.
Amosova E; Andrejev E; Zaderey I; Rudenko U; Ceconi C; Ferrari R
Cardiovasc Drugs Ther; 2011 Dec; 25(6):531-7. PubMed ID: 21830063
[TBL] [Abstract][Full Text] [Related]
31. Ivabradine: from molecular basis to clinical effectiveness.
Riccioni G
Adv Ther; 2010 Mar; 27(3):160-7. PubMed ID: 20419486
[TBL] [Abstract][Full Text] [Related]
32. Ivabradine: Do the Benefits Outweigh the Risks?
Alshammari TM
J Cardiovasc Pharmacol Ther; 2017 May; 22(3):210-218. PubMed ID: 27698078
[TBL] [Abstract][Full Text] [Related]
33. [Ivabradine (Procoralan)].
Lancellotti P
Rev Med Liege; 2008 Apr; 63(4):220-4. PubMed ID: 18575078
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.
Tardif JC; Ford I; Tendera M; Bourassa MG; Fox K;
Eur Heart J; 2005 Dec; 26(23):2529-36. PubMed ID: 16214830
[TBL] [Abstract][Full Text] [Related]
35. Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction.
Camici PG; Gloekler S; Levy BI; Skalidis E; Tagliamonte E; Vardas P; Heusch G
Int J Cardiol; 2016 Jul; 215():1-6. PubMed ID: 27104917
[TBL] [Abstract][Full Text] [Related]
36. Heart rate-lowering efficacy and respiratory safety of ivabradine in patients with obstructive airway disease: a randomized, double-blind, placebo-controlled, crossover study.
Majewski S; Slomka S; Zielinska-Wyderkiewicz E; Ciebiada M; Gorski P
Am J Cardiovasc Drugs; 2012 Jun; 12(3):179-88. PubMed ID: 22409211
[TBL] [Abstract][Full Text] [Related]
37. Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate: an analysis of the ASSOCIATE study.
Tardif JC; Ponikowski P; Kahan T;
Int J Cardiol; 2013 Sep; 168(2):789-94. PubMed ID: 23138014
[TBL] [Abstract][Full Text] [Related]
38. I(f) inhibition in cardiovascular diseases.
Thollon C; Vilaine JP
Adv Pharmacol; 2010; 59():53-92. PubMed ID: 20933199
[TBL] [Abstract][Full Text] [Related]
39. The importance of reducing heart rate in cardiovascular diseases: effects of Ivabradine.
Vizzardi E; Bonadei I; D'Aloia A; Del Magro F; Piovanelli B; Bontempi L; Curnis A; Dei Cas L
Minerva Med; 2011 Oct; 102(5):373-9. PubMed ID: 22193347
[TBL] [Abstract][Full Text] [Related]
40. Drug insight: If inhibitors as specific heart-rate-reducing agents.
Borer JS
Nat Clin Pract Cardiovasc Med; 2004 Dec; 1(2):103-9. PubMed ID: 16265314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
